IDOMENEO - Is Treatment Reality in Vascular Medicine Evidence-based and Follows Guideline Recommendations? A Project for Quality Development Exemplified by Peripheral Arterial Disease (PAD)

Sponsor
Universitätsklinikum Hamburg-Eppendorf (Other)
Overall Status
Unknown status
CT.gov ID
NCT03098290
Collaborator
GermanVasc (Other), University Heart Center Hamburg (Other), BARMER GEK Germany (Other), University of Hamburg-Eppendorf (Other)
10,000
43
35
232.6
6.6

Study Details

Study Description

Brief Summary

The prevalence of peripheral arterial disease (PAD) and the proportion of endovascular procedures for treatment are increasing worldwide. For many cases of treatment or procedures no randomized controlled trials (RCT) or results from meta-analyses are so far available. The decision for treatment and selection of procedure is therefore not uncommonly left up to the personal expertise of the physician. The IDOMENEO study represents a multistage multimethodological project for healthcare research and quality assurance in interdisciplinary vascular medicine, which undertakes a comprehensive examination of this topic. Various methods and data sources (even routine data) are linked in a meaningful way. The essential components of the total project are implementation of a register platform (GermanVasc), which conforms to data protection and data security as well as the development of instruments for valid measurement of the quality of life of patients with PAD. The data protection-conform linking of primary data in the register and routine data of the consortium partner BARMER should also enable validation of the data sources.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Catheter-based endovascular revascularization
  • Procedure: Bypass-Surgery
  • Procedure: Endarterectomy

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
10000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
IDOMENEO: Multimethodical and Multistage Registry-based Longitudinal Study Project to Collect Primary Registry Data and Health Insurance Claims Data of Patients Invasively Treated for Peripheral Artery Disease (PAD) in Germany
Actual Study Start Date :
May 1, 2018
Anticipated Primary Completion Date :
Mar 31, 2021
Anticipated Study Completion Date :
Apr 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Intermittent Claudication

Mild to severe claudication

Procedure: Catheter-based endovascular revascularization
(e.g. PTA-alone, Bare-Metal or Drug-Eluting-Stent, Covered Stent, Atherectomy, Mechanical Thrombectomy, Scoring Ballon, Cutting Ballon)
Other Names:
  • ER
  • Procedure: Bypass-Surgery
    Venous or alloplastic or comparable Bypass
    Other Names:
  • Bypass
  • Procedure: Endarterectomy
    Endarterectomy, Patchplasty
    Other Names:
  • TEA
  • Ischaemic Rest Pain

    Procedure: Catheter-based endovascular revascularization
    (e.g. PTA-alone, Bare-Metal or Drug-Eluting-Stent, Covered Stent, Atherectomy, Mechanical Thrombectomy, Scoring Ballon, Cutting Ballon)
    Other Names:
  • ER
  • Procedure: Bypass-Surgery
    Venous or alloplastic or comparable Bypass
    Other Names:
  • Bypass
  • Procedure: Endarterectomy
    Endarterectomy, Patchplasty
    Other Names:
  • TEA
  • Critical Limb Threatening Ischaemia

    Ulcers, Necrosis, Gangrene

    Procedure: Catheter-based endovascular revascularization
    (e.g. PTA-alone, Bare-Metal or Drug-Eluting-Stent, Covered Stent, Atherectomy, Mechanical Thrombectomy, Scoring Ballon, Cutting Ballon)
    Other Names:
  • ER
  • Procedure: Bypass-Surgery
    Venous or alloplastic or comparable Bypass
    Other Names:
  • Bypass
  • Procedure: Endarterectomy
    Endarterectomy, Patchplasty
    Other Names:
  • TEA
  • Outcome Measures

    Primary Outcome Measures

    1. All-cause Mortality [12 Months]

      Death from any reason

    2. Lower Extremity Amputation [12 Months]

      Amputation of lower extremity

    3. Amputation-free Survival [12 Months]

      Long-term-survival without any major amputation

    4. Patency of Revascularization [12 Months]

      Patency of treated vessel

    5. Quality of Life (SF12, WIQ) [12 Months]

      Combined questionnaire including 26 questions using QoL-SF12 and Walking Impairment Questionnaire

    6. Ambulation [12 Months]

    7. Myocardial infarction [12 Months]

    8. Stroke or TIA [12 Months]

    9. Stent or Graft Thrombosis [12 Months]

    10. Functional Status [12 Months]

    11. Modified Rutherford Classification [12 Months]

    12. Foot Infection [12 Months]

    13. Tissue Loss [12 Months]

    14. New Revascularization [12 Months]

    15. Major Adverse Cardiovascular Events (MACE, MACCE) [12 Months]

    16. Major Adverse Limb Events (MALE) [12 Months]

    17. Surgical Site Infection [12 Months]

    18. Major Bleeding Complication [12 Months]

    19. Acute kidney injury (AKI) requiring hemodialysis [At time of discharge (in-hospital period)]

      As defined by the National Kidney Foundation.

    20. Ankle-Brachial-Index [12 Months]

    21. Occurrence of target vessel dissection [At time of discharge (in-hospital period)]

      Any new dissection of the target vessel related to the procedure

    22. Compartment Syndrome [At time of discharge (in-hospital period)]

    23. Graft or Device Failure [At time of discharge (in-hospital period)]

    24. Distal Embolisation [At time of discharge (in-hospital period)]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Symptomatic peripheral artery disease (intermittent claudication or critical limb ischemia)

    • Invasive treatment (open-surgical or endovascular)

    • Informed consent was obtained

    Exclusion Criteria:
    • No informed consent was obtained

    • Acute limb ischemia without any chronic symptomatic PAD

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Zentralklinik Bad Berka GmbH Bad Berka Germany
    2 Herz- und Gefäßzentrum Bad Bevensen Bad Bevensen Germany
    3 Universitäts-Herzzentrum Freiburg - Bad Krozingen (UHZ) Bad Krozingen Germany
    4 Kerckhoff-Klinik Bad Nauheim Bad Nauheim Germany
    5 Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin Berlin Germany
    6 Ev. Krankenhaus Hubertus Berlin Germany
    7 HELIOS Klinikum Berlin-Buch Berlin Germany
    8 Asklepios Klinik Birkenwerder Birkenwerder Germany
    9 St. Josef Hospital I Katholisches Klinikum der Ruhr-Universität Bochum Bochum Germany
    10 Gemeinschaftskrankenhaus Bonn, Haus St. Petrus Bonn Germany
    11 GFO Kliniken Bonn, Betriebsstätte St. Marien Bonn Germany
    12 Klinikum Chemnitz gGmbH Chemnitz Germany
    13 Carl-Thiem-Klinikum Cottbus Cottbus Germany
    14 Klinikum Darmstadt GmbH Darmstadt Germany
    15 Städtisches Klinikum Dresden Friedrichstadt Dresden Germany
    16 University Medical Center Düsseldorf Düsseldorf Germany
    17 HELIOS Klinikum Erfurt Erfurt Germany
    18 Elisabeth-Krankenhaus Essen Essen Germany
    19 Frankfurter RotKreuz-Kliniken e.V. Frankfurt Germany
    20 Universitäts-Herzzentrum Freiburg - Bad Krozingen (UHZ) Freiburg Germany
    21 Klinikum Fulda Fulda Germany
    22 University Heart Center Hamburg Hamburg Germany 20246
    23 Agaplesion Diakonieklinikum Hamburg Hamburg Germany
    24 Universitätsklinikum Jena Jena Germany
    25 SRH-Klinikum-Karlsbad-Langensteinbach Karlsbach Germany
    26 Klinikum Karlsruhe Karlsruhe Germany
    27 Agaplesion Diakonie Kliniken Kassel Kassel Germany
    28 Kath. Karl-Leisner-Klinikum I Marienhospital Kevelaer Kevelaer Germany
    29 Universitätsklinikum Schleswig-Holstein, Campus Kiel Kiel Germany
    30 St. Bonifatius Hospital Lingen Lingen Germany
    31 Universitätsklinikum Schleswig-Holstein, Campus Lübeck Lübeck Germany
    32 Klinikum Magdeburg gGmbH Magdeburg Germany
    33 Theresienkrankenhaus Mannheim Mannheim Germany
    34 Kliniken Maria Hilf GmbH Mönchengladbach Germany
    35 Ev. Krankenhaus Mühlheim an der Ruhr Mühlheim Germany
    36 HELIOS Klinikum München West München Germany
    37 Isarklinikum München München Germany
    38 Friedrich-Ebert-Krankenhaus Neumünster Neumünster Germany
    39 Klinikum Peine Peine Germany
    40 Imland Kliniken Rendsburg Rendsburg Germany
    41 Klinikum Rheine I Mathias Spital Rheine Germany
    42 Klinikum Stadt Soest Soest Germany
    43 Klinikum Mutterhaus der Borromäerinnen gGmbH (Mitte) Trier Germany

    Sponsors and Collaborators

    • Universitätsklinikum Hamburg-Eppendorf
    • GermanVasc
    • University Heart Center Hamburg
    • BARMER GEK Germany
    • University of Hamburg-Eppendorf

    Investigators

    • Principal Investigator: Christian-Alexander Behrendt, Dr., Universitätsklinikum Hamburg-Eppendorf

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    Responsible Party:
    Christian Behrendt, Dr., Universitätsklinikum Hamburg-Eppendorf
    ClinicalTrials.gov Identifier:
    NCT03098290
    Other Study ID Numbers:
    • VF1_2016-028
    • 01VSF16008
    • 01VSF18035
    • DRKS00014649
    First Posted:
    Mar 31, 2017
    Last Update Posted:
    Apr 14, 2020
    Last Verified:
    Apr 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Christian Behrendt, Dr., Universitätsklinikum Hamburg-Eppendorf
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 14, 2020